Hexavalent Acellular Vaccine Now Available in Paraguay’s National Vaccination Scheme

The Ministry of Health of Paraguay reported this Monday that the hexavalent acellular vaccine, which protects infants against six diseases, is incorporated into the National Vaccination Scheme.


Two Uruguayan ex-military officers are sentenced for crimes during the dictatorship

The Paraguayan entity reported that the diseases against which the compound immunizes are: diphtheria, tetanus, whooping cough, hepatitis B, Haemophilus influenzae B and poliomyelitis.

With the acquisition, through the Revolving Fund of the Pan American Health Organization (PAHO), it will be officially available in the public sector, starting June 19, the entity said.

“The hexavalent vaccine is equivalent to the Pentavalent vaccine plus the Anti-polio vaccine, which is placed in the national scheme separately. With the hexavalent, only one injection is applied that replaces the two mentioned”, the portfolio pointed out.

The Ministry of Health indicated that this vaccine is currently only available in the private sector and “it is expected that some two hundred and fifty thousand doses will be received at the beginning, which will be distributed to the country’s vaccination centers.”

For his part, the director of the Expanded Immunization Program (PAI), Héctor Castro, stated “that for us it is extremely important, it positions us in the region after Chile as one of the countries that incorporates into its vaccination program, a vaccine safe, effective, that protects against six diseases in childhood, for an integral development of children and completely free of charge”.

Read more:  People between 50 and 54 years old can get vaccinated against covid-19 without an appointment - Health

2023-06-06 01:26:29
#Paraguay #incorporates #hexavalent #pediatric #vaccine #immunization #schedule #teleSUR

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent News

Editor's Pick